Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.

Topf, Joel; Wooldridge, Thomas; McCafferty, Kieran; Schömig, Michael; Csiky, Botond; Zwiech, Rafal; Wen, Warren; Bhaduri, Sarbani; Munera, Catherine; Lin, Rong; Jebara, Alia; Cirulli, Joshua; Menzaghi, Frédérique

Topf, Joel; Wooldridge, Thomas; McCafferty, Kieran; Schömig, Michael; Csiky, Botond; Zwiech, Rafal; Wen, Warren; Bhaduri, Sarbani; Munera, Catherine; Lin, Rong; Jebara, Alia; Cirulli, Joshua; Menzaghi, Frédérique.

Afiliación

Topf J; Oakland University William Beaumont School of Medicine, Auburn Hills, Michigan.
Wooldridge T; Nephrology and Hypertension Associates, Ltd, Tupelo, Mississippi.
McCafferty K; The Royal London Hospital-Barts Health NHS Trust, London, United Kingdom.
Schömig M; Dialysezentrum Heilbronn, Heilbronn, Germany.
Csiky B; Fresenius Medical Care Szatellita Dialysis Center Pecs, Pecs, Hungary.
Zwiech R; Norbert Barlicki Memorial Teaching Hospital No. 1 of the Medical University of Lodz, Lodz, Poland.
Wen W; Cara Therapeutics, Stamford, CT.
Bhaduri S; Bhaduri Biotech Consulting, El Paso, TX.
Munera C; Cara Therapeutics, Stamford, CT.
Lin R; Biostatistical Consulting Inc, Lexington, MA.
Jebara A; Cara Therapeutics, Stamford, CT.
Cirulli J; Cara Therapeutics, Stamford, CT.
Menzaghi F; Cara Therapeutics, Stamford, CT.

Kidney Med ; 4(8): 100512, 2022 Aug.

Article en En | MEDLINE | ID: mdl-36016762

Palabras clave

Chronic kidney disease; difelikefalin; efficacy; pruritus; κ-opioid receptor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Kidney Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google